MX2024000762A - Inhibidores peptidicos del receptor de interleucina-23. - Google Patents

Inhibidores peptidicos del receptor de interleucina-23.

Info

Publication number
MX2024000762A
MX2024000762A MX2024000762A MX2024000762A MX2024000762A MX 2024000762 A MX2024000762 A MX 2024000762A MX 2024000762 A MX2024000762 A MX 2024000762A MX 2024000762 A MX2024000762 A MX 2024000762A MX 2024000762 A MX2024000762 A MX 2024000762A
Authority
MX
Mexico
Prior art keywords
interleukin
receptor
peptide inhibitors
disorders
pharmaceutically acceptable
Prior art date
Application number
MX2024000762A
Other languages
English (en)
Spanish (es)
Inventor
Jing Zhang
Chengzao Sun
Ashok Bhandari
Raymond J Patch
Elisabetta Bianchi
Raffaele Ingenito
Danila Branca
Roberto Costante
Sandeep Somani
Santhosh Neelamkavil
Stephanie A Barros
Charles Hendrick
James Daniel
Tran Trung Tran
Brian Frederick
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of MX2024000762A publication Critical patent/MX2024000762A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Epidemiology (AREA)
MX2024000762A 2021-07-14 2022-07-14 Inhibidores peptidicos del receptor de interleucina-23. MX2024000762A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163221806P 2021-07-14 2021-07-14
PCT/US2022/037221 WO2023288028A2 (en) 2021-07-14 2022-07-14 Peptide inhibitors of interleukin-23 receptor

Publications (1)

Publication Number Publication Date
MX2024000762A true MX2024000762A (es) 2024-04-18

Family

ID=84920532

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024000762A MX2024000762A (es) 2021-07-14 2022-07-14 Inhibidores peptidicos del receptor de interleucina-23.

Country Status (11)

Country Link
US (1) US20240409598A1 (cg-RX-API-DMAC7.html)
EP (1) EP4370531A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024525780A (cg-RX-API-DMAC7.html)
KR (1) KR20240034222A (cg-RX-API-DMAC7.html)
CN (1) CN117999274A (cg-RX-API-DMAC7.html)
AU (1) AU2022310354A1 (cg-RX-API-DMAC7.html)
CA (1) CA3226539A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024000762A (cg-RX-API-DMAC7.html)
TW (1) TW202332683A (cg-RX-API-DMAC7.html)
UY (1) UY39856A (cg-RX-API-DMAC7.html)
WO (1) WO2023288028A2 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4091624A1 (en) 2013-03-15 2022-11-23 Protagonist Therapeutics, Inc. Hepcidin analogues and uses thereof
CA2949215C (en) 2014-05-16 2023-03-14 Protagonist Therapeutics, Inc. .alpha.4.beta.7 integrin thioether peptide antagonists
SG10201810154WA (en) 2014-07-17 2018-12-28 Protagonist Therapeutics Inc Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
WO2018022937A1 (en) 2016-07-27 2018-02-01 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
WO2019157268A1 (en) 2018-02-08 2019-08-15 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
MX2022008740A (es) 2020-01-15 2022-09-23 Janssen Biotech Inc Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
AU2021383828A1 (en) 2020-11-20 2023-07-06 Janssen Pharmaceutica Nv Compositions of peptide inhibitors of interleukin-23 receptor
KR20240034224A (ko) 2021-07-14 2024-03-13 얀센 바이오테크 인코포레이티드 인터류킨-23 수용체의 지질화된 펩티드 억제제
EP4652179A1 (en) * 2023-01-16 2025-11-26 Janssen Pharmaceutica NV Lipidated peptide inhibitors of interleukin-23 receptor
EP4652180A2 (en) * 2023-01-16 2025-11-26 Janssen Pharmaceutica NV Peptide inhibitors of interleukin-23 receptor
TW202440615A (zh) * 2023-01-16 2024-10-16 比利時商健生藥品公司 介白素-23受體之肽抑制劑
KR20250139359A (ko) * 2023-01-31 2025-09-23 얀센 파마슈티카 엔브이 인터류킨-23 수용체의 결정질 펩티드 억제제의 제조 방법
AU2024233524A1 (en) * 2023-03-03 2025-10-16 Janssen Pharmaceutica Nv Interleukin-23 receptor antagonist peptides for use in the treatment of psoriasis
EP4471048A1 (en) 2023-06-01 2024-12-04 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor
EP4471049A1 (en) 2023-06-01 2024-12-04 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor
CN121794283A (zh) 2023-09-08 2026-04-03 赛诺菲 作为选择性il-23受体抑制剂的新型肽
CN121909205A (zh) 2023-09-08 2026-04-21 赛诺菲 作为选择性il-23受体抑制剂的新型肽
WO2026013260A1 (en) 2024-07-12 2026-01-15 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor
WO2026026816A1 (zh) * 2024-07-30 2026-02-05 西藏海思科制药有限公司 白介素-23受体的肽抑制剂及其用途
WO2026041110A1 (zh) * 2024-08-22 2026-02-26 上海瀚辰星泰医药科技有限公司 一种多肽化合物及其应用
WO2026046292A1 (zh) * 2024-08-28 2026-03-05 西藏海思科制药有限公司 白介素-23受体的肽抑制剂的药物组合物及其制备方法和用途
WO2026138829A1 (zh) * 2024-12-23 2026-07-02 上海医药集团股份有限公司 多肽抑制剂及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9605027B2 (en) * 2011-06-14 2017-03-28 Medical Diagnostic Laboratories, Llc Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
SG10201810154WA (en) * 2014-07-17 2018-12-28 Protagonist Therapeutics Inc Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
HK1257747A1 (zh) * 2015-07-15 2019-10-25 Protagonist Therapeutics Inc. 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途
US10787490B2 (en) * 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
JP2020505352A (ja) * 2017-01-18 2020-02-20 プロタゴニスト セラピューティクス, インコーポレイテッド インターロイキン−23受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用
CA3104418A1 (en) * 2018-07-12 2020-01-16 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
AU2020311395A1 (en) * 2019-07-10 2022-02-03 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
SMT202500254T1 (it) * 2020-01-15 2025-09-12 Janssen Biotech Inc Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie

Also Published As

Publication number Publication date
JP2024525780A (ja) 2024-07-12
WO2023288028A2 (en) 2023-01-19
US20240409598A1 (en) 2024-12-12
EP4370531A2 (en) 2024-05-22
UY39856A (es) 2023-02-28
TW202332683A (zh) 2023-08-16
CA3226539A1 (en) 2023-01-19
WO2023288028A3 (en) 2023-02-23
EP4370531A4 (en) 2025-09-03
CN117999274A (zh) 2024-05-07
AU2022310354A1 (en) 2024-02-29
KR20240034222A (ko) 2024-03-13

Similar Documents

Publication Publication Date Title
UY39856A (es) Inhibidores peptídicos del receptor de interleucina-23
AR126457A1 (es) Inhibidores peptídicos bicíclicos del receptor de interleuquina-23
CO2023007172A2 (es) Composiciones de inhibidores peptídicos del receptor de interleucina-23
UY39857A (es) Inhibidores peptídicos lipidados del receptor de interleucina-23
MX2022008740A (es) Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
CL2024004039A1 (es) Péptido inhibidor monocíclico de un receptor de interleuquina-23; composición farmacéutica; y su uso.
AR119389A1 (es) Inhibidores de péptidos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias
CO2024005925A2 (es) Moléculas pequeñas para el tratamiento del cáncer
MX2024009477A (es) Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de estos
MX2020006460A (es) Compuestos de anillo 5,5 fusionado sustituido con diarilo como inhibidores de c5ar.
MX2023003348A (es) Compuestos y composiciones como moduladores de señalización tlr.
MX2025008274A (es) Formulaciones de inhibidores peptidicos lipidados del receptor de interleucina-23
CO2025010249A2 (es) Inhibidores peptídicos del receptor de interleucina-23
DOP2025000151A (es) Inhibidores peptídicos del receptor de interleucina-23
MX2025008741A (es) Inhibidores de la proteina 3 que contiene los dominios nod, lrr y pirina (nlrp3)
MX2025008922A (es) Metodos para preparar inhibidores peptidicos cristalinos del receptor de interleucina-23
WO2024155547A3 (en) Peptide inhibitors of interleukin-23 receptor
UY40134A (es) Motor de presión negativa